R. E. Glover
Impact in
-
- Antibiotic Use and Resistance
- Modeling and Simulation top 2%
- COVID-19 epidemiological studies
Papers in
-
- Antibiotic Use and Resistance 15
-
- Primary Care and Health Outcomes 4
- Co-authors
- Gwenan M. Knight (4 shared papers)Clare Chandler (3 shared papers)Esther van Kleef (1 shared paper)Rumina Hasan (1 shared paper)Christopher Finn McQuaid (1 shared paper)Karin Gallandat (1 shared paper)Ioana D. Olaru (1 shared paper)Naomi M. Fuller (1 shared paper)
- Journals
- Journal of Clinical Epidemiology (4 papers)The Lancet Microbe (3 papers)BMJ (3 papers)Antibiotics (2 papers)European Journal of Public Health (2 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
R. E. Glover
38 papers receiving 866 citations
R. E. Glover's Hit Papers
Peers
Comparison fields: 5 of 133
- Applied Microbiology and Biotechnology 179
- Modeling and Simulation 148
- Molecular Medicine 102
- Infectious Diseases 206
- Emergency Medical Services 37
Countries citing papers authored by R. E. Glover
This map shows the geographic impact of R. E. Glover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. E. Glover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. E. Glover more than expected).
Fields of papers citing papers by R. E. Glover
This network shows the impact of papers produced by R. E. Glover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. E. Glover. The network helps show where R. E. Glover may publish in the future.
Co-authors
The 25 scholars most cited alongside R. E. Glover, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Antimicrobial resistance and COVID-19: Intersections and implications Hit paper breakdown → | 2021 | 248 |
| 2 | 2020 | 126 | |
| 3 | 2015 | 82 | |
| 4 | 2015 | 75 | |
| 5 | 2006 | 61 | |
| 6 | 2019 | 51 | |
| 7 | 2021 | 23 | |
| 8 | 2022 | 20 | |
| 9 | 2022 | 16 | |
| 10 | 2018 | 15 | |
| 11 | 2021 | 15 | |
| 12 | 2022 | 15 | |
| 13 | 1952 | 14 | |
| 14 | 1951 | 14 | |
| 15 | 2023 | 12 | |
| 16 | 2024 | 11 | |
| 17 | 2023 | 10 | |
| 18 | 2022 | 9 | |
| 19 | 2021 | 9 | |
| 20 | 1953 | 8 |
About R. E. Glover
R. E. Glover is a scholar working on Applied Microbiology and Biotechnology, General Health Professions, Infectious Diseases, Epidemiology and Economics and Econometrics, having authored 47 papers that have together received 893 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (15 papers), Primary Care and Health Outcomes (4 papers), Global Public Health Policies and Epidemiology (4 papers), Pharmaceutical industry and healthcare (3 papers), Pharmaceutical Economics and Policy (3 papers), Antibiotic Resistance in Bacteria (3 papers), Bacterial Identification and Susceptibility Testing (3 papers) and COVID-19 epidemiological studies (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (179 citations), Modeling and Simulation (148 citations), Molecular Medicine (102 citations), Infectious Diseases (206 citations) and Emergency Medical Services (37 citations). R. E. Glover has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Gwenan M. Knight, Clare Chandler, Esther van Kleef, Rumina Hasan, Christopher Finn McQuaid, Karin Gallandat, Ioana D. Olaru, Naomi M. Fuller, Sam Willcocks and Quentin J. Leclerc. Their work appears in journals such as Journal of Clinical Epidemiology, The Lancet Microbe, BMJ, Antibiotics and European Journal of Public Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.